GL1X · GenesisL1 explorer

MolNFT v1 · #10721 · protein

Structural mechanism of enzyme mistargeting in hereditary kidney stone disease in vitro

1J04 · Alanine--glyoxylate aminotransferase: “Structural mechanism of enzyme mistargeting in hereditary kidney stone disease in vitro”. X-ray diffraction, 1 ligand (AOA), 2 pockets (best druggability 0.43). MolNFT v1 #10721 on GenesisL1…

PDB
1J04
Type
protein
Length
387 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alanine--glyoxylate aminotransferase
EC
2.6.1.51, 2.6.1.44
UniProt
P21549
Ligands
AOA
Pockets
2 · best druggability 0.43

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlanine--glyoxylate aminotransferase (EC 2.6.1.51, 2.6.1.44)protein38741% helix, 13% strandP21549

Ligands and binding sites

  • AOA · (aminooxy)acetic acid · ligand · chains A
  • GOL · Glycerol · additive · 7 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1520.430.8313empty
2810.360.7618empty

Modifications

Observed in the structure: 1 modified (cofactor).

Compared structures

  • 1J04 · Structural mechanism of enzyme mistargeting in hereditary kidney stone disease in vitro · the same entry in another collection · chain A against A, TM-score 1.00
  • P21549 · AlphaFold monomer V2.0 prediction for serine--pyruvate aminotransferase (P21549) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.